Introduction
The CAR-T/Cell Therapy Center of Ewha Womans University Blood Cancer Hospital is composed of specialized medical personnel with many years of experience in treating blood cancers and performing hematopoietic stem cell transplants, and provides personalized treatment optimized for each patient. In particular, CAR-T cell therapy is a cutting-edge method of immunotherapy that genetically modifies a patient's immune cells (T cells) to effectively target and eliminate cancer cells, thereby offering new hope for patients with refractory blood cancers that do not respond to conventional treatment methods. To ensure that CAR-T cell therapy is administered safely and effectively, the center operates a multidisciplinary integrated treatment system. Specialists in infectious diseases, neurology, and intensive care work together to promptly address any side effects or emergency situations that may arise during treatment. Furthermore, because managing side effects is critical in CAR-T therapy, the center has established rigorous protocols and a robust safety system that makes patient safety the highest priority. Dedicated nurses also accompany patients throughout the treatment process, addressing their concerns and guiding them through each step so as to ensure a comfortable experience. In addition, the center actively participates in the development of next-generation cell therapies and research on new medicines, leading the advancement of future blood cancer treatments. The CAR-T/Cell Therapy Center of Ewha Womans University Blood Cancer Hospital is committed to providing patients with the best possible treatment opportunities and establishing a new standard for cell therapy.
Banner Title
